Align Technology (ALGN): Record Aligner Shipments and Stifel Stays Bullish at $210

Align Technology, Inc. (NASDAQ:ALGN) is one of the best medical technology stocks to buy right now. On May 18, Stifel analyst Jonathan Block reaffirmed his Buy rating and $210 price target on Align Technology, Inc. (NASDAQ:ALGN) following a routine update to the firm’s financial model.

Align Technology (ALGN): Record Aligner Shipments and Stifel Stays Bullish at $210

Align Technology (ALGN): Record Aligner Shipments and Stifel Stays Bullish at $210

The model update incorporated clear aligner volume data that Align Technology has recently started disclosing regularly alongside its earnings reports and presentations. Stifel also reviewed Align’s latest 10-Q filing and used it to inform observations on valuation, the analyst said.

Block stated that Align’s Q1 2026 earnings influenced the updated model heavily. In the earnings report shared on April 29, revenue came in at $1.04 billion, up 6.2% year over year. Management credited the revenue growth to record clear aligner shipments and higher average selling prices. Clear aligner revenue specifically surged 7.4% year over year to $856 million, driven by volume growth, price increases, favorable foreign exchange, and lower net revenue deferrals. GAAP EPS for the quarter was $1.57 per diluted share, up from $1.26 in Q1 2025. This EPS jump came on the back of higher gross margins, lower tax rate, and buybacks reducing the share count, management noted.

Stifel’s $210 target has been in place since February, when the firm raised it from $200 after concluding that Align could deliver mid-single-digit comparable growth for the year. The firm calculated that this growth would support a share price in the $205-$215 range.

Align Technology, Inc. (NASDAQ:ALGN) is a medical technology company specializing in digital orthodontics and restorative dentistry solutions. The company is best known for its Invisalign clear aligner system, along with its iTero intraoral scanners and exocad dental CAD/CAM software platforms used by orthodontists and dentists worldwide.

While we acknowledge the risk and potential of ALGN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ALGN and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 7 Best Augmented Reality Penny Stocks to Buy and 10 Best Gene Therapy Stocks to Buy in 2026.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1